Aura Launch Rescheduled For July 13
The launch of NASAs Aura spacecraft atop a Boeing Delta II rocket is rescheduled for Tuesday, July 13. Launch is set for the opening of a three-minute window at 6:01:59 a.m. EDT (3:01:59 a.m. PDT).
Yesterday, during routine pre-launch checks, engineers discovered an improper assembly of the fairing ordnance detonator connector within the Delta II booster fairing. This detonator acts to separate the fairing during flight. Mission managers decided an additional 48 hours was needed to correct the matter.
On launch day, July 13, programming on NASA Television will begin at 4 a.m. EDT (1 a.m. PDT) for the start of cryogenic fueling of the Delta II. The launch commentary will begin at 4:30 a.m. EDT (1:30 a.m. PDT).
Media wishing to participate in a photo opportunity for Mobile Service Tower rollback at Space Launch Complex 2 should meet at the main gate of Vandenberg Air Force Base on California State Road 1 at 5 p.m. Monday, July 12. Media covering the launch should meet at the main gate at 2 a.m. Tuesday, July 13, for escort to the Delta press site on north Vandenberg Air Force Base.
Media needing accreditation for the launch should call Air Force Lt. Michelle Mayo at 805/606-3595 in the 30th Space Wing Public Affairs Office.
An Aura recorded launch status for the news media is available by dialing 805-734-2693.
All latest news from the category: Physics and Astronomy
This area deals with the fundamental laws and building blocks of nature and how they interact, the properties and the behavior of matter, and research into space and time and their structures.
innovations-report provides in-depth reports and articles on subjects such as astrophysics, laser technologies, nuclear, quantum, particle and solid-state physics, nanotechnologies, planetary research and findings (Mars, Venus) and developments related to the Hubble Telescope.
New drug candidate uses novel absorption method to target cancer cells in mice
By using the lymphatic system as a storage reservoir, researchers found they could optimize drug concentrations to simultaneously target two molecular signaling pathways responsible for cancer growth. A team of…